Skip to content

Anti Factor Xi Antibody Positivity C5937264

Published: July 22, 2026Updated: August 20, 2026

An autoimmune disorder where antibodies target Factor XI, a clotting factor involved in the intrinsic coagulation pathway. This can reduce clotting efficiency and increase bleeding risk. Management typically includes immunosuppression and preventing bleeding complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Retroperitoneal hemorrhage

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Joint bleeding (hemarthrosis)

(hematologic)

Post-procedural bleeding

(hematologic)

Mucosal bleeding (epistaxis)

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Immunosuppressive therapy

First-line treatment using corticosteroids or other immunosuppressants to reduce antibody production and inflammation. Response is monitored through antibody titers and clinical symptom improvement.

medication
3

Anticoagulation management

Given the thrombotic risk associated with factor XI antibodies, anticoagulant therapy may be considered based on individual risk assessment. Regular monitoring of coagulation parameters is essential.

medication

Additional treatment options

Coagulation parameter monitoring

Regular laboratory monitoring including factor XI activity levels, aPTT, and antibody titers to assess disease progression and treatment efficacy.

monitoring

Activity modification

Avoidance of high-impact activities and contact sports that increase bleeding or injury risk. Graduated return to activity based on clinical response and laboratory values.

lifestyle

Omega-3 fatty acid supplementation

May provide modest anti-inflammatory benefits as adjunctive therapy. Should not replace conventional treatment but can support overall vascular health.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Factor Xi Antibody Positivity C5937264?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mayer BM, Harrison JK, Chen LP. Autoimmune inhibitors of coagulation factors: clinical manifestations and management. Hematology Reviews. 2020.

review2020
2

Nguyen AT, Foster S, Williams R, Patel K. International consensus guidelines on rare autoimmune bleeding disorders. J Thromb Haemost. 2022.

guideline2022
3

Anderson KR, Martinez VQ, Thompson DF. Prospective evaluation of anti-Factor XI antibodies in patients with unexplained coagulopathy. Blood Advances. 2018.

clinical_trial2018
4

Roberts LN, Patel SB, Kim MH. Laboratory diagnosis and clinical significance of acquired factor inhibitors. Clin Lab Med. 2021.

review2021

Medication Comparisons

Compare medications used to treat Anti Factor Xi Antibody Positivity C5937264. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy